Group 1 - The company held its 23rd meeting of the 5th Board of Directors on September 9, 2025, with all 9 directors present, and the meeting was deemed legal and effective [2][3]. - The Board approved the proposal to use temporarily idle raised funds to supplement working capital, with a total amount not exceeding RMB 250 million, for a period not exceeding 12 months [12][18]. - The Board also approved the proposal to use temporarily idle raised funds for cash management, with a total amount not exceeding RMB 28 million, also for a period not exceeding 12 months [23][35]. Group 2 - The company aims to improve the efficiency of fund usage and reduce financial costs while ensuring that the normal construction of fundraising projects is not affected [15][27]. - The cash management investment products will be low-risk financial products with high safety and liquidity, issued by banks or other financial institutions [23][29]. - The company will ensure compliance with relevant regulations and maintain transparency in the management of these funds [35][36].

Group 1 - The core issue is that Hengshang Energy (603137) failed to reassess the feasibility of its fundraising project, the "Intelligent Production Base Construction Project in Jiangmen, Guangdong," after significant changes occurred, leading to insufficient risk disclosure [1][2] - As of the disclosure date of the 2025 semi-annual report, the project had an investment amount and progress of 0, indicating no funds were allocated or utilized for the project [1] - The company did not adequately disclose the risks associated with changes in market demand in South China related to the Jiangmen project in its fundraising reports for 2023 and the first half of 2024 [1][2] Group 2 - The Shanghai Stock Exchange issued a regulatory warning to Hengshang Energy's former general manager Zhou Zuqing and former board secretary Hua Fengjuan for their roles in the violations, which contravened various regulations [2] - The company is required to take effective measures to rectify the violations, conduct a thorough compliance risk assessment, and submit a rectification report signed by all board members within one month of receiving the decision [2] - The company must ensure that similar issues do not recur by strictly adhering to regulations and fulfilling its information disclosure obligations [2]

Core Viewpoint - Shenhuo Co., Ltd. and seven executives received a regulatory letter from the Shenzhen Stock Exchange due to four major compliance violations, highlighting serious internal control deficiencies within the company [1][3]. Group 1: Compliance Violations - Shenhuo Co., Ltd. failed to disclose non-operating fund transactions with its controlling shareholder and other related parties as required [4]. - The company did not timely disclose significant issues related to competition with its controlling shareholder, which is a critical regulatory concern in the capital market [4]. - There were serious irregularities in the use and management of raised funds, including the replacement of raised funds with self-raised funds without following necessary procedures [4]. - The operation of the company's three meetings (shareholders' meeting, board of directors, and supervisory board) was found to be non-compliant, indicating potential flaws in decision-making and supervision mechanisms [4]. Group 2: Accountability of Executives - The regulatory action extended beyond the company to hold specific executives accountable for the violations, including the current chairman, general manager, and other key management personnel [5][6]. - Seven executives were identified as having failed to fulfill their duties, with direct responsibility for the violations outlined in the regulatory letter [6]. - The Shenzhen Stock Exchange emphasized the need for Shenhuo Co., Ltd. and its executives to learn from this incident and adhere strictly to relevant laws and regulations regarding information disclosure [6].

Core Points - The article outlines the fundraising management system of Leo Group Co., Ltd, emphasizing the need for compliance with relevant laws and regulations to protect investors' rights [2][3][17] - The system specifies the definition of raised funds and the management of excess funds, requiring the establishment of internal controls for fund storage, usage, and supervision [2][3][5] - The company is mandated to use raised funds strictly for the purposes stated in the prospectus and prohibits any unauthorized changes in usage [6][7][8] Fund Storage - The company must open a special account for raised funds, ensuring that these funds are managed separately and not mixed with other funds [3][5] - A tripartite supervision agreement must be signed with the sponsor or independent financial advisor and the commercial bank within one month of the funds being received [5][6] - The agreement should include details such as account numbers, project specifics, and notification procedures for significant withdrawals [6][10] Fund Usage - Raised funds should primarily be used for the company's main business and cannot be used for high-risk investments or to provide financial assistance to others [7][8] - The company must ensure the authenticity and fairness of fund usage, taking measures to prevent misuse by controlling shareholders or related parties [8][9] - Any changes in the use of raised funds or the use of excess funds must be approved by the board of directors and, in some cases, the shareholders' meeting [10][11] Excess Fund Management - The company should prioritize the use of excess funds for filling funding gaps in projects, temporarily supplementing working capital, and cash management [15][16] - Any temporary use of excess funds for cash management or working capital must be justified and approved by the board [16][17] - The company must disclose the necessity and rationale for using excess funds for cash management or working capital [16][17] Project Changes - Changes in the use of raised funds are defined, including project cancellations or changes in implementation methods, which require board approval [18][19] - The company must conduct feasibility analyses for new investment projects to ensure they have good market prospects and profitability [19][20] - If funds remain after project completion, they can be used for permanent working capital, subject to specific conditions and approval processes [20][21] Fund Management and Supervision - The board is required to conduct biannual reviews of the progress of fundraising projects and issue reports on fund storage and usage [22][23] - Independent financial advisors must conduct regular checks on the management of raised funds and report any significant violations or risks [23][24] - The company must address any adverse audit opinions from accountants regarding fund management and disclose corrective measures [24][25]

Fundraising Overview - The company has received approval from the China Securities Regulatory Commission to issue 4,800,000 convertible bonds at a face value of RMB 100 each, raising a total of RMB 480 million, with a net amount of RMB 466,974,528.31 after deducting issuance costs [1][2] - The funds will be stored in a dedicated account and a tripartite supervision agreement has been signed with the underwriter and the bank [2][3] Tripartite Supervision Agreement - The company established a special account at China Merchants Bank for the project "High-end Electronic Vacuum Devices and Integrated Systems Intelligent Manufacturing Expansion Project" [3][4] - The agreement outlines that the funds in the special account are solely for the designated project, with the underwriter responsible for supervising the fund's usage [4][5] Securities Name Change - The company will change its stock abbreviation from "Guoli Co., Ltd." to "Guoli Electronics" effective September 11, 2025, while the stock code remains unchanged [9][12] - The name change reflects the company's strategic focus on the electronics sector, enhancing brand recognition and aligning with its core business [11][12] Convertible Bond Buyback Notice - The company announced a buyback price of RMB 100.22 per bond during the buyback period from September 2 to September 8, 2025 [15][22] - Holders of the convertible bonds have the option to sell back their bonds at this price, which includes accrued interest [18][23]

Group 1 - The company has approved the use of idle raised funds not exceeding 90 million yuan to temporarily supplement working capital, with a usage period of no more than 12 months from the board's approval date [2][6][7] - The company has established a special account for raised funds, which will only be used for temporarily supplementing working capital, and has signed a tripartite supervision agreement with the sponsor and the bank [3][5][6] - The company raised a total of 1,075,950,160 yuan from its initial public offering, with a net amount of 978,057,381.28 yuan after deducting issuance costs [2][4] Group 2 - The company will have 15,639,463 shares listed for circulation on September 15, 2025, following the issuance of shares to specific investors [15][16] - The total share capital of the company will increase to 277,885,415 shares after the issuance, and further to 333,462,498 shares after a capital reserve transfer [17][18] - The independent financial advisor has confirmed that the shareholders of the restricted shares have complied with their commitments, and the listing of these shares meets regulatory requirements [19][20] Group 3 - The company will participate in a collective performance briefing for the medical device industry on September 17, 2025, to communicate its half-year results and address investor questions [33][34] - Investors can submit questions for the briefing from September 10 to September 16, 2025, and the company will respond to commonly asked questions during the event [35][36]

Core Viewpoint - The company has established a specialized management system for the storage and use of raised funds to enhance the efficiency of fund utilization and protect investors' legal rights [1][2]. Fund Storage - Raised funds must be stored in a dedicated account approved by the board of directors, and cannot be used for non-raising purposes [7][8]. - A tripartite supervision agreement must be signed with the sponsor and the commercial bank within one month of the funds being received [8][3]. Fund Usage - The company must adhere to strict approval procedures for fund usage, ensuring that all expenditures are documented and approved by relevant authorities [9][10]. - Funds should primarily be used for the main business operations, and any changes in usage must be approved by the board and disclosed [10][20]. - If the actual use of funds deviates from the planned usage due to unforeseen circumstances, the company must report to the board and disclose the reasons [9][10]. Management and Supervision - The company is required to disclose the actual usage of raised funds accurately and completely, with a special report submitted to the board every six months [25][15]. - Independent directors and the audit committee must continuously monitor the management and usage of raised funds [26][27]. Changes in Fund Usage - Any changes to the investment projects funded by raised funds must be approved by the board and shareholders, with independent opinions required [20][22]. - If there are surplus funds after project completion, they can only be used for other projects after board approval [18][19].

Core Points - The document outlines the fundraising management measures for Zhuhai Hengji Daxin International Chemical Storage Co., Ltd, aiming to standardize the company's operations and protect the rights of investors [2][3] - It emphasizes the importance of proper use and management of raised funds, ensuring they align with the company's business objectives and legal regulations [6][7] Fundraising Overview - The term "raised funds" refers to capital obtained through stock issuance or other equity-like securities for specific purposes, excluding funds raised for equity incentive plans [2] - The company must establish a special account for raised funds, ensuring that these funds are not mixed with other financial resources [3] Fund Management and Usage - The board of directors is responsible for thoroughly evaluating the feasibility of investment projects funded by raised capital, ensuring they have good market prospects and profitability [3][6] - The company must disclose the actual usage of raised funds accurately and completely, and any significant deviations from the planned investment must be reported promptly [7][8] Fund Usage Restrictions - Raised funds should primarily be used for the company's main business activities and must not be used for high-risk investments or financial assistance to others [6][9] - Any changes in the use of raised funds require board approval and must be disclosed to shareholders [9][10] Monitoring and Reporting - The company is required to maintain detailed records of the usage of raised funds and undergo regular audits to ensure compliance with regulations [14][15] - Independent financial advisors or sponsors must conduct periodic checks on the management and usage of raised funds, reporting any irregularities to the relevant authorities [15][16]

Core Viewpoint - The company has announced the establishment of a special account for raised funds and signed a tripartite supervision agreement for the management of these funds, aimed at ensuring compliance with regulations and protecting investor interests [1][5]. Fundraising Overview - The company approved the temporary use of up to 90 million yuan of idle raised funds to supplement working capital, with a usage period not exceeding 12 months from the board's approval date [2]. - The company raised a total of 1,075,950,160 yuan from its initial public offering (IPO) by issuing 51,333,500 shares at a price of 20.96 yuan per share, with a net amount of 978,892,778.72 yuan after deducting issuance costs [2][3]. - Additionally, the company raised 203,920,127.60 yuan through a share issuance for asset acquisition, issuing 13,032,886 shares at a price of 16.42 yuan per share, after deducting related issuance costs [3][4]. Special Account and Supervision Agreement - A special account has been opened at Shanghai Pudong Development Bank for the storage of temporarily supplemented working capital, with a tripartite supervision agreement signed between the company, the bank, and the financial advisor, Dongfang Securities [5][6]. - The agreement stipulates that the funds in the special account are exclusively for temporary working capital and cannot be used for other purposes [6][7]. - The financial advisor is responsible for supervising the use of the raised funds and must conduct regular checks and provide monthly account statements to the company [6][8]. Compliance and Legal Framework - The agreement is governed by relevant laws and regulations, including the Company Law and the Securities Law of the People's Republic of China, ensuring that all parties adhere to legal requirements [8][9]. - Any disputes arising from the agreement will be resolved through negotiation or arbitration in Shanghai, with the arbitration ruling being final and binding [9].

Core Points - The document outlines the management and usage of funds raised by Shandong Hualu Hengsheng Chemical Co., Ltd, emphasizing compliance with relevant laws and regulations [1][2][3] - The company must ensure that raised funds are used specifically for designated purposes, primarily related to its main business operations, and must not engage in financial investments [1][2][3] - The document establishes internal control systems for fund management, including approval processes and risk control measures [2][3][4] Fund Storage - The company is required to store raised funds in a centralized manner to facilitate supervision, using dedicated accounts [9][10] - A tripartite supervision agreement must be established with the underwriter or independent financial advisor and the commercial bank where the funds are stored [11][12] - The company must ensure that funds are not used for purposes outside the approved investment projects [13][14] Fund Usage - The company must strictly adhere to the usage plan outlined in the issuance documents and cannot change the purpose of the funds without proper approval [14][15] - In cases where the investment project cannot be completed on time, the company must report to the exchange and disclose reasons for delays [16][17] - Any changes in the investment project must be approved by the board and disclosed to stakeholders [18][19] Fund Management and Supervision - The company is required to provide accurate and complete disclosures regarding the actual usage of raised funds [33][34] - The underwriter must conduct ongoing supervision and report any irregularities to regulatory authorities [35][36] - The company’s accounting department must maintain detailed records of fund expenditures and project investments [37]